• AHA
  • ESC
  • ASCO
  • ACC
  • RSNA
  • ISC
  • SABCS
  • AACR
  • APA
  • Archives
株式会社ヘスコインターナショナルは、法令を遵守し本サイトをご利用いただく皆様の個人情報の取り扱いに細心の注意を払っております。

Gonadotropin-releasing hormone agonist therapy for prostate cancer appears to increase risk for diabetes and coronary heart disease

Japanese adults with diabetes may have a higher risk of cancer overall and in several specific organs, including the liver, pancreas and kidney, according to an article in the September 25 issue of Archives of Internal Medicine.

"Clarification of the association between diabetes mellitus and cancer in populations with an increasing prevalence, such as Japanese persons, is a crucial task, not only from the causative point of view but also with regard to the formulation of clinical strategies and public health policies for the target population," the authors wrote.

Manami Inoue, MD, PhD, National Cancer Center, Tokyo, and colleagues studied the association in 97,771 Japanese adults (46,548 men, 51,223 women; average age, 51 years) age 40 to 69 years who were enrolled between 1990 and 1994. Participants completed a lifestyle questionnaire at baseline that included information about smoking, alcohol drinking, medical history, physical activity and food and beverage intake. They were also asked if they had ever been diagnosed with diabetes or taken diabetes medications. Researchers consulted the national registry of Japanese residents, major hospitals, cancer registries and death certificates to track deaths and cancer cases.

At the beginning of the study, 3,097 men (6.7 percent) and 1,571 women (3.1 percent) had a history of diabetes. By the end of the study's follow-up in 2003, 6,462 participants had developed cancer, including 3,907 men (366 of whom had diabetes) and 2,555 women (104 with diabetes).

Men with diabetes had a 27-percent higher risk of developing cancer than men without diabetes; the risk was especially high for liver, kidney and pancreatic cancer. Women with diabetes had a 21-percent higher risk of cancer than those without (although this increased risk was not statistically significant). However, there was a significantly higher risk for stomach and liver cancer and a borderline higher risk for ovarian cancer.

Researchers suspect that excess insulin in diabetic patients may promote growth in the cells of organs including the liver and pancreas, increasing cancer risk. In addition, changes in sex hormone levels associated with diabetes could contribute to ovarian cancer in women and prostate cancer in men.

"Despite the biological plausibility of the association, several issues should be considered when discussing the role of diabetes mellitus as a cause of cancer," the authors warned. For example, common health conditions and risk factors such as obesity might contribute to both diabetes and cancer, and some types of cancer may actually cause diabetes. In addition, those being treated for diabetes often visit a physician more frequently than those without a chronic health condition, and this increased vigilance could lead to more cancer diagnoses. "These issues should likely be considered as alternative factors affecting the association between diabetes mellitus and cancer, directly or otherwise."

Regardless of whether diabetes causes cancer, cancer causes diabetes or a common third cause links them both, it is likely that the rapidly increasing incidence of diabetes among Japanese residents in recent years heralds a future increase in cases of cancer, especially those kinds most closely linked with diabetes, concluded the authors.


DOLについて - 利用規約 -  会員規約 -  著作権 - サイトポリシー - 免責条項 - お問い合わせ
Copyright 2000-2025 by HESCO International, Ltd.